U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07411742) titled 'Mass Balance Study of [14C] D-2570' on Feb. 09.
Brief Summary: Radiolabeled drug substance balance clinical studies are commonly used methods to elucidate the metabolic and excretion characteristics of drugs in the human body. They are widely applied in the research and development of innovative drugs both domestically and internationally, and their safety has been validated through extensive human trials. The primary objectives of this study are as follows:
To quantitatively analyze the total radioactive activity (TRA) in urine and feces, thereby determining the radioactive recovery rate in humans and identifying the primary excre...